J
Jun Ma
Researcher at Harbin Institute of Technology
Publications - 1523
Citations - 58397
Jun Ma is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 97, co-authored 1338 publications receiving 39643 citations. Previous affiliations of Jun Ma include Shenyang Aerospace University & University of Technology, Sydney.
Papers
More filters
Journal ArticleDOI
Oxygen Vacancy-Induced Nonradical Degradation of Organics: Critical Trigger of Oxygen (O2) in the Fe-Co LDH/Peroxymonosulfate System.
TL;DR: In this article, the authors show that the ubiquitous oxygen vacancies existing in metallic compounds can activate peroxymonosulfate (PMS) for water treatment under environmental conditions, especially oxygenated surroundings.
Journal ArticleDOI
Selective H2O2 electrosynthesis by O-doped and transition-metal-O-doped carbon cathodes via O2 electroreduction: A critical review
Wei Zhou,Liang Xie,Jihui Gao,Roya Nazari,Haiqian Zhao,Xiaoxiao Meng,Fei Sun,Guangbo Zhao,Jun Ma +8 more
TL;DR: In this paper, the authors provide a critical review of the advances of the oxygen reduction reaction (ORR) pathway and O-doping effects, followed by the experimental preparation methods for o-doped carbon, including chemical oxidation and electrochemical oxidation.
Journal ArticleDOI
The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China
Lei Chen,Yan Ping Mao,Fang Yun Xie,Li Zhi Liu,Ying Sun,Li Tian,Ling Long Tang,Ai Hua Lin,Li Li,Jun Ma +9 more
TL;DR: It seems reasonable to downstage T3 as T2 and reject nodal greatest dimension from the N-staging system in the future revised edition of the UICC/AJCC staging system for nasopharyngeal carcinoma in patients treated with intensity-modulated radiotherapy.
Journal ArticleDOI
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
Hong-Hu Zhu,Depei Wu,Xin Du,Xi Zhang,Lin Liu,Jun Ma,Zong-Hong Shao,Hanyun Ren,Jianda Hu,Kai-Lin Xu,Jing-Wen Wang,Yongping Song,Mei-Yun Fang,Juan Li,Xiao-Yan Yan,Xiao-Jun Huang +15 more
TL;DR: A pilot study of treatment with oral arsenic realgar-Indigo naturalis formula (RIF) plus ATRA without chemotherapy, which has a more convenient route of administration than the standard intravenous regimen, showed high efficacy, and non-inferiority was confirmed in the per-protocol population.
Journal ArticleDOI
Soil plastispheres as hotpots of antibiotic resistance genes and potential pathogens.
TL;DR: It is suggested that plastispheres are habitats in which an increased potential pathogen abundance is spatially co-located with an increased abundance of ARGs under global change.